The $100,000 H-1B visa fee has significantly affected who biopharma companies hire, according to two experts. It’s not the only program adjustment affecting foreign-born job seekers’ odds of working in the U.S.
We bring you the latest updates from BioSpace: Biotech, Pharmaceutical and Clinical Research News through a simple and fast subscription.
We can deliver your news in your inbox, on your phone or you can read them here on this website on your personal news page.
Unsubscribe at any time without hassle.
BioSpace: Biotech, Pharmaceutical and Clinical Research News's title: BioSpace: Biotech, Pharmaceutical and Clinical Research News